Alexion Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (39)

Latest Posts

About This Stock More About This Stock
Are Biotech ETFs In Trouble As Coronavirus Dims Guidance?
Article By: Zacks Investment Research
Saturday, May 9, 2020 7:49 PM EDT
Although the coronavirus seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite impressive results, most of these biotechs have been seeing declining share prices since the earnings releases.
In this article: ALXN, IBB, AMGN, BIIB, GILD, BBH, XBI
Read
Biotech M&A Deal Looks Too Rich For Its Blood
Article By: Lipper Alpha Insight
Wednesday, May 6, 2020 10:46 AM EDT
Alexion Pharmaceuticals (ALXN) is either buying Portola Pharmaceuticals (PTLA) on the cheap at $1.4 billion, or paying a whopping premium – it all depends on your starting date.
In this article: ALXN, PTLA
Read
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
Article By: Zacks Investment Research
Wednesday, January 22, 2020 4:00 PM EDT
A highlight of five big drug/biotech companies, which are expected to deliver positive earnings surprise in their upcoming quarterly earnings announcements.
In this article: AZN, MRK, ALXN, AMGN, ABBV
Read
Alexion To Acquire Achillion Pharma For $930M
Article By: Benzinga
Wednesday, October 16, 2019 9:06 AM EDT
Alexion Pharma will buy Achillion Pharma for the initial value of $930 million, or $6.30 per share in cash plus added contingent considerations for a total potential value of $8.30 per share.
In this article: ALXN, ACHN
Read
3 Big Drug/Biotech Stocks Set To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Saturday, October 12, 2019 10:00 AM EDT
Overall, relatively newer drugs have been driving the top line of most of the big shots backed by higher demand - a trend we expect to have benefited third-quarter sales.
In this article: LLY, ALXN, AMGN Also: JNJ
Read

PARTNER HEADLINES

Latest Tweets for $ALXN

No tweets yet!